nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—PIM1—GMCSF-mediated signaling events—NRAS—gallbladder cancer	0.0463	0.0463	CbGpPWpGaD
Mitoxantrone—PIM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—BCL2—gallbladder cancer	0.0463	0.0463	CbGpPWpGaD
Mitoxantrone—PIM1—GMCSF-mediated signaling events—KRAS—gallbladder cancer	0.0398	0.0398	CbGpPWpGaD
Mitoxantrone—BTK—EPO signaling pathway—BCL2—gallbladder cancer	0.0379	0.0379	CbGpPWpGaD
Mitoxantrone—PIM1—GMCSF-mediated signaling events—HRAS—gallbladder cancer	0.0339	0.0339	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—BCL2—gallbladder cancer	0.0325	0.0325	CbGpPWpGaD
Mitoxantrone—BTK—IL-5 Signaling Pathway—BCL2—gallbladder cancer	0.0317	0.0317	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—NRAS—gallbladder cancer	0.024	0.024	CbGpPWpGaD
Mitoxantrone—BTK—Kit receptor signaling pathway—BCL2—gallbladder cancer	0.0232	0.0232	CbGpPWpGaD
Mitoxantrone—BTK—Class I PI3K signaling events—NRAS—gallbladder cancer	0.0213	0.0213	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—KRAS—gallbladder cancer	0.0207	0.0207	CbGpPWpGaD
Mitoxantrone—BTK—EPO signaling pathway—HRAS—gallbladder cancer	0.0205	0.0205	CbGpPWpGaD
Mitoxantrone—BTK—IL-5 Signaling Pathway—KRAS—gallbladder cancer	0.0202	0.0202	CbGpPWpGaD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—TP53—gallbladder cancer	0.0193	0.0193	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—ERBB4—gallbladder cancer	0.0184	0.0184	CbGpPWpGaD
Mitoxantrone—BTK—Class I PI3K signaling events—KRAS—gallbladder cancer	0.0184	0.0184	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—HRAS—gallbladder cancer	0.0176	0.0176	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—ERBB4—gallbladder cancer	0.0173	0.0173	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—ERBB4—gallbladder cancer	0.0173	0.0173	CbGpPWpGaD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—EGFR—gallbladder cancer	0.017	0.017	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—ERBB4—gallbladder cancer	0.016	0.016	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—ERBB3—gallbladder cancer	0.0159	0.0159	CbGpPWpGaD
Mitoxantrone—BTK—Class I PI3K signaling events—HRAS—gallbladder cancer	0.0156	0.0156	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—ERBB3—gallbladder cancer	0.015	0.015	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—ERBB3—gallbladder cancer	0.015	0.015	CbGpPWpGaD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—TP53—gallbladder cancer	0.0143	0.0143	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—ERBB3—gallbladder cancer	0.0138	0.0138	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—KEAP1—gallbladder cancer	0.0136	0.0136	CbGpPWpGaD
Mitoxantrone—BTK—Kit receptor signaling pathway—HRAS—gallbladder cancer	0.0126	0.0126	CbGpPWpGaD
Mitoxantrone—BTK—Fc-epsilon receptor I signaling in mast cells—HRAS—gallbladder cancer	0.0122	0.0122	CbGpPWpGaD
Mitoxantrone—BTK—BCR signaling pathway—HRAS—gallbladder cancer	0.0113	0.0113	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—ERBB2—gallbladder cancer	0.00996	0.00996	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—ERBB2—gallbladder cancer	0.00937	0.00937	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	0.00937	0.00937	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.00912	0.00912	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—ERBB2—gallbladder cancer	0.00868	0.00868	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—HRAS—gallbladder cancer	0.00844	0.00844	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.00831	0.00831	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.00831	0.00831	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TP53—gallbladder cancer	0.00828	0.00828	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KEAP1—gallbladder cancer	0.00824	0.00824	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00785	0.00785	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—NRAS—gallbladder cancer	0.00758	0.00758	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—NRAS—gallbladder cancer	0.00713	0.00713	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	0.00713	0.00713	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—EGFR—gallbladder cancer	0.00691	0.00691	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—ERBB4—gallbladder cancer	0.00672	0.00672	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.00667	0.00667	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—NRAS—gallbladder cancer	0.0066	0.0066	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—KRAS—gallbladder cancer	0.00652	0.00652	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	0.0065	0.0065	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—EGFR—gallbladder cancer	0.0065	0.0065	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ERBB4—gallbladder cancer	0.00645	0.00645	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—gallbladder cancer	0.00626	0.00626	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.00614	0.00614	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—KRAS—gallbladder cancer	0.00614	0.00614	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—EGFR—gallbladder cancer	0.00601	0.00601	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.0059	0.0059	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—ERBB3—gallbladder cancer	0.00581	0.00581	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00574	0.00574	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—KRAS—gallbladder cancer	0.00568	0.00568	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ERBB3—gallbladder cancer	0.00558	0.00558	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—HRAS—gallbladder cancer	0.00555	0.00555	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—HRAS—gallbladder cancer	0.00522	0.00522	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.00522	0.00522	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—HRAS—gallbladder cancer	0.00483	0.00483	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00398	0.00398	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ERBB4—gallbladder cancer	0.00391	0.00391	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00376	0.00376	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—BCL2—gallbladder cancer	0.00375	0.00375	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—ERBB2—gallbladder cancer	0.00364	0.00364	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ERBB2—gallbladder cancer	0.0035	0.0035	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ERBB3—gallbladder cancer	0.00338	0.00338	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00334	0.00334	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—gallbladder cancer	0.0032	0.0032	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—NRAS—gallbladder cancer	0.00277	0.00277	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—NRAS—gallbladder cancer	0.00266	0.00266	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—EGFR—gallbladder cancer	0.00252	0.00252	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—EGFR—gallbladder cancer	0.00242	0.00242	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—KRAS—gallbladder cancer	0.00238	0.00238	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—KRAS—gallbladder cancer	0.00229	0.00229	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—BCL2—gallbladder cancer	0.00218	0.00218	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ERBB2—gallbladder cancer	0.00212	0.00212	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—HRAS—gallbladder cancer	0.00203	0.00203	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HRAS—gallbladder cancer	0.00195	0.00195	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.00194	0.00194	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00189	0.00189	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB4—gallbladder cancer	0.00163	0.00163	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NRAS—gallbladder cancer	0.00161	0.00161	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EGFR—gallbladder cancer	0.00147	0.00147	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—gallbladder cancer	0.00144	0.00144	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB3—gallbladder cancer	0.00141	0.00141	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KRAS—gallbladder cancer	0.00139	0.00139	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00131	0.00131	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00124	0.00124	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—gallbladder cancer	0.00118	0.00118	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.0011	0.0011	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB2—gallbladder cancer	0.000881	0.000881	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NRAS—gallbladder cancer	0.000671	0.000671	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—gallbladder cancer	0.000611	0.000611	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—gallbladder cancer	0.000577	0.000577	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—gallbladder cancer	0.000491	0.000491	CbGpPWpGaD
